...
search icon
lucd-img

Lucid Diagnostics Inc Share Price

LUCD
NAQ
$1.38
+$0.04
(2.99%)
1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Lucid Diagnostics Inc Analyst Forecast

Lucid Diagnostics Inc Share Price Chart

Lucid Diagnostics Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$175.67M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.15M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.22
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.95 L
$1.8 H
$1.38

About Lucid Diagnostics Inc, Common Stock

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Lucid Diagnostics Inc Stock Returns

Time FrameLUCDSectorS&P500
1-Week Return13.11%1.07%0.74%
1-Month Return14.05%1.46%1.28%
3-Month Return35.29%3.51%3.6%
6-Month Return38.87%15.29%7.31%
1-Year Return-13.21%7.7%11.97%
3-Year Return4.55%21.02%72.07%
5-Year Return-88.27%37.81%76.01%

Lucid Diagnostics Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-500.00K377.00K2.43M4.35M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":11.5,"profit":true},{"date":"2022-12-31","value":8.67,"profit":true},{"date":"2023-12-31","value":55.87,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue-585.00K3.61M8.48M8.27M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":6.9,"profit":true},{"date":"2022-12-31","value":42.63,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":97.5,"profit":true}]
Gross Profit-(85.00K)(3.24M)(6.05M)(3.92M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Gross Margin-(17.00%)(858.62%)(249.18%)(90.20%)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-17,"profit":false},{"date":"2022-12-31","value":-858.62,"profit":false},{"date":"2023-12-31","value":-249.18,"profit":false},{"date":"2024-12-31","value":-90.2,"profit":false}]
Operating Expenses8.28M27.33M52.93M42.43M42.13M[{"date":"2020-12-31","value":15.64,"profit":true},{"date":"2021-12-31","value":51.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":80.16,"profit":true},{"date":"2024-12-31","value":79.59,"profit":true}]
Operating Income(8.28M)(27.42M)(56.17M)(48.48M)(46.05M)[{"date":"2020-12-31","value":-827951700,"profit":false},{"date":"2021-12-31","value":-2741900000,"profit":false},{"date":"2022-12-31","value":-5617100000,"profit":false},{"date":"2023-12-31","value":-4848200000,"profit":false},{"date":"2024-12-31","value":-4605200000,"profit":false}]
Total Non-Operating Income/Expense3.00(1.32M)15.00K(4.29M)819.00K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-160.93,"profit":false},{"date":"2022-12-31","value":1.83,"profit":true},{"date":"2023-12-31","value":-524.05,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(8.28M)(28.08M)(56.17M)(52.67M)(45.53M)[{"date":"2020-12-31","value":-827951700,"profit":false},{"date":"2021-12-31","value":-2807800000,"profit":false},{"date":"2022-12-31","value":-5617100000,"profit":false},{"date":"2023-12-31","value":-5266600000,"profit":false},{"date":"2024-12-31","value":-4552900000,"profit":false}]
Income Taxes(8.28M)659.00K1.71M2.33M7.50B[{"date":"2020-12-31","value":-0.11,"profit":false},{"date":"2021-12-31","value":0.01,"profit":true},{"date":"2022-12-31","value":0.02,"profit":true},{"date":"2023-12-31","value":0.03,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes479.00(28.74M)(57.88M)(55.00M)(7.54B)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-5999373.7,"profit":false},{"date":"2022-12-31","value":-12083298.54,"profit":false},{"date":"2023-12-31","value":-11481650.31,"profit":false},{"date":"2024-12-31","value":-1574431941.54,"profit":false}]
Income From Continuous Operations(8.28M)(28.08M)(56.17M)(56.76M)(45.53M)[{"date":"2020-12-31","value":-827951700,"profit":false},{"date":"2021-12-31","value":-2807800000,"profit":false},{"date":"2022-12-31","value":-5617100000,"profit":false},{"date":"2023-12-31","value":-5676400000,"profit":false},{"date":"2024-12-31","value":-4552900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(8.28M)(28.08M)(56.17M)(52.67M)(45.53M)[{"date":"2020-12-31","value":-827951700,"profit":false},{"date":"2021-12-31","value":-2807800000,"profit":false},{"date":"2022-12-31","value":-5617100000,"profit":false},{"date":"2023-12-31","value":-5266600000,"profit":false},{"date":"2024-12-31","value":-4552900000,"profit":false}]
EPS (Diluted)(0.97)(1.82)(1.38)(1.22)(1.02)[{"date":"2020-12-31","value":-97.11,"profit":false},{"date":"2021-12-31","value":-181.6,"profit":false},{"date":"2022-12-31","value":-138,"profit":false},{"date":"2023-12-31","value":-122,"profit":false},{"date":"2024-12-31","value":-102,"profit":false}]

Lucid Diagnostics Inc Ratios

Lucid Diagnostics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

LUCD
Cash Ratio 1.81
Current Ratio 1.90
Quick Ratio 1.87

Lucid Diagnostics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

LUCD
ROA (LTM) -79.17%
ROE (LTM) -331.24%

Lucid Diagnostics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

LUCD
Debt Ratio Lower is generally better. Negative is bad. 0.51
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.49

Lucid Diagnostics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

LUCD
Trailing PE NM
Forward PE NM
P/S (TTM) 39.93
P/B 2.16
Price/FCF NM
EV/R 46.60
EV/Ebitda NM

FAQs

What is Lucid Diagnostics Inc share price today?

Lucid Diagnostics Inc (LUCD) share price today is $1.38

Can Indians buy Lucid Diagnostics Inc shares?

Yes, Indians can buy shares of Lucid Diagnostics Inc (LUCD) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LUCD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Lucid Diagnostics Inc be purchased?

Yes, you can purchase fractional shares of Lucid Diagnostics Inc (LUCD) via the Vested app. You can start investing in Lucid Diagnostics Inc (LUCD) with a minimum investment of $1.

How to invest in Lucid Diagnostics Inc shares from India?

You can invest in shares of Lucid Diagnostics Inc (LUCD) via Vested in three simple steps:

  • Click on Sign Up or Invest in LUCD stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Lucid Diagnostics Inc shares
What is Lucid Diagnostics Inc 52-week high and low stock price?

The 52-week high price of Lucid Diagnostics Inc (LUCD) is $1.8. The 52-week low price of Lucid Diagnostics Inc (LUCD) is $0.95.

What is Lucid Diagnostics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Lucid Diagnostics Inc (LUCD) is

What is Lucid Diagnostics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Lucid Diagnostics Inc (LUCD) is 2.16

What is Lucid Diagnostics Inc dividend yield?

The dividend yield of Lucid Diagnostics Inc (LUCD) is 0.00%

What is the Market Cap of Lucid Diagnostics Inc?

The market capitalization of Lucid Diagnostics Inc (LUCD) is $175.67M

What is Lucid Diagnostics Inc's stock symbol?

The stock symbol (or ticker) of Lucid Diagnostics Inc is LUCD

How Can Investors Use Lucid Diagnostics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Lucid Diagnostics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Lucid Diagnostics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Lucid Diagnostics Inc shares for Indian investors?

When investing in Lucid Diagnostics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Lucid Diagnostics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Lucid Diagnostics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Lucid Diagnostics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Lucid Diagnostics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top